About the journal · ISSN 2474-3585 · Open Access Pub
About the Journal of Preventive Medicine and Care
The Journal of Preventive Medicine and Care publishes research on disease prevention, early detection, risk reduction, preventive care delivery, and population health.
Identity
What JPMC is
The Journal of Preventive Medicine and Care (JPMC) is an open-access, peer-reviewed journal in preventive medicine and public health. It is one title in the Open Access Pub portfolio; the two are separate entities with separate responsibilities, and the split below says which is which.
- Journal
- Journal of Preventive Medicine and CareShort form JPMC
- ISSN
- 2474-3585Online
- DOI prefix
- 10.14302Registered with Crossref
- License
- CC BY 4.0Authors retain copyright
- Peer review
- Single-blindDouble-blind on request
- First article
- June 2015Most recent December 2024
The journal
- Responsible for
- Scope, peer review, editorial decisions, corrections and retractions
- Guided by
- An international editorial board of 11 members
- Subject
- Preventive medicine, public health and preventive care delivery
- Contact
- [email protected]
The publisher
- Publisher
- Open Access Pub
- Responsible for
- Production, hosting, Crossref DOI registration and metadata deposit
- Submission system
- ManuscriptZone (external portal)
- Other titles
- The full Open Access Pub list
Purpose
What the journal is for, and who reads it
JPMC exists to publish evidence that reduces disease burden across populations: research that improves health outcomes, strengthens preventive care delivery, and supports evidence-based policy in clinical, community and public health settings. Its emphasis is practical translation and measurable prevention impact.
Preventive medicine clinicians
Practitioners who need evidence that can be applied in primary care clinics and preventive care pathways rather than only interpreted.
Public health leaders
Program and agency staff designing screening, immunization, behavioral and community prevention initiatives.
Health system decision-makers
Those responsible for prevention services, care coordination and the financing and evaluation that sustain them.
Prevention researchers
Investigators in epidemiology, health behavior, implementation science and health services research who translate findings into practice.
Policy analysts
Readers who need prevention evidence connected to financing, service delivery and regulatory decisions.
Educators and trainees
CC BY 4.0 permits translation and educational reuse for public health training without seeking further permission.
The journal serves prevention researchers, clinicians, public-health practitioners, policy analysts, educators, and trainees. Its open license supports attributed educational reuse and translation.
The record
Published record
JPMC has published 41 records across 11 issues and 3 volumes since 2015.
The archive lists each record with its article type, authors, DOI, publication date, volume, issue, and full-text links.
Scope
What belongs here, and where the boundary falls
JPMC assesses manuscripts against the prevention continuum: primary prevention through risk reduction and health promotion; secondary prevention through screening, early detection and timely intervention; tertiary prevention through care models that reduce complications; and population health strategies that improve access and equity.
JPMC supports the article types below. Authors whose manuscript does not clearly match a listed type should contact the editorial office before submission.
Original research
Trials with prevention outcomes, cohort studies, surveillance and population analyses.
3,000-6,000 words · structured abstract, 300 words · up to 10 figures/tables
Systematic review
Evidence synthesis on a defined prevention question.
4,000-8,000 words · structured abstract, 300 words · up to 12 figures/tables
Program evaluation
Prevention programs evaluated in real settings against measurable outcomes.
2,500-5,000 words · structured abstract, 250 words · up to 8 figures/tables
Brief report
Short, complete studies with a clear prevention finding.
1,500-2,500 words · unstructured abstract, 200 words · up to 4 figures/tables
Case report
A prevention-relevant clinical or community case reported in accordance with CARE. Confirm article-specific limits with the editorial office.
Editorial
An invited or pre-approved scholarly commentary on prevention policy, evidence, or practice. Contact the editorial office before preparation.
Authors who are uncertain about scope fit are asked to contact the editorial office before submitting. Category limits, manuscript structure and reporting standards are set out in the Instructions for Authors; priority topics, settings and populations are on the Aims & Scope page.
Governance
How a publication decision is made
Peer review is Single-blind (double-blind on request). Every manuscript passes through the same four stages, and the two lists below state plainly what a decision rests on and what it does not.
Editorial screening
An editor screens the submission for scope and ethics before it goes further.
Assignment to reviewers
In-scope manuscripts are assigned to qualified reviewers working in prevention fields.
Editorial synthesis
An editor synthesizes the reviewer feedback against methodological rigor, scope alignment and prevention relevance.
Decision and revision guidance
The author receives a clear decision category with explicit revision guidance. Decisions may be appealed with a clear, evidence-based rationale; appeals are reviewed by senior editors.
What a decision rests on
- The quality of the science and the rigor of the method
- Alignment with the journal’s prevention scope
- Potential public health impact
- Methodological rigor, transparency and clinical relevance, which every review is asked to emphasize
What a decision is not based on
- Payment of the article processing charge
- The author’s funding source
- Any commercial or financial interest
- Use of any optional paid service, including language editing
No fee, service or role confers any advantage in the review or acceptance of a manuscript. The full policy set, including appeals and corrections, is on the Editorial Policies page; the board is listed on the Editorial Board page.
Research integrity
What the journal requires of every submission
These requirements are published in full on the journal’s own policy pages. JPMC states that it complies with COPE guidance and ethical publishing best practice.
Ethics approval and consent
Studies involving human participants must include institutional review board approval and informed consent, with justification for any waiver.
Trial registration
Interventional clinical trials must be registered in an accepted public trial registry at or before the first participant provides consent for enrollment. Report the registry name, registration number, and registration date.
Competing interests
Authors and reviewers disclose financial and non-financial conflicts, and funding sources and sponsor roles are reported.
Similarity screening
All submissions are screened for plagiarism.
Data availability
Data sharing is encouraged and data availability statements are required when appropriate, with repository links or access pathways.
Corrections and retractions
Errors identified after publication are corrected or retracted. Suspected misconduct is handled under COPE guidance; authorship disputes are managed according to international standards.
Authors are asked to use the established reporting guideline relevant to their study design. Each guideline below is bound to the design it covers, exactly as the Instructions for Authors bind them — a flat list of acronyms would drop the qualifier that makes the requirement meaningful.
- CONSORT
- trials and interventions
- STROBE
- observational studies
- PRISMA
- reviews and evidence syntheses
- TIDieR
- intervention reporting
- SQUIRE
- quality improvement studies
Rights, access & charges
What publication costs, and what authors keep
One charge, one figure, stated once. Nothing is payable to submit, and nothing is payable if a manuscript is declined.
- Open access
- Every article is free to read and download from publication. There are no subscription or reader charges.
- License
- Creative Commons Attribution 4.0 International (CC BY 4.0), permitting reuse, distribution and adaptation with attribution, and translation and educational reuse for public health training. Read the license
- Copyright
- Authors retain copyright and grant JPMC the right to publish. Authors may reuse their work in future publications, institutional repositories and academic teaching materials.
- Article processing charge
- USD 1,800, applied to all article types, payable only after acceptance. There are no submission fees.
- Waivers
- Partial waivers are evaluated case by case, with regard to differences in funding availability across regions and institutions. A waiver request does not affect how a manuscript is reviewed.
- What the charge covers
- Editorial assessment and peer-review coordination, copyediting and formatting, XML, PDF and HTML production, Crossref DOI registration and metadata distribution, ethics and plagiarism screening, online hosting, and post-publication corrections and metadata maintenance.
Questions
About this journal
Submit prevention research to JPMC
If your study shows how risk can be reduced, disease detected earlier, or prevention delivered better, the editors would like to see it.
Submit a manuscriptJournal of Preventive Medicine and Care · ISSN 2474-3585 · Published by Open Access Pub · Editorial policies · Instructions for authors · Contact the editorial office